avelumab
merck,pfizer
['javelin,bladder,100', 'javelin,bladder', 'avelumab', 'urothelial', 'javelin,100', 'bladder 100', 'urothelial carcinoma', 'bladder']
esmo 2022: avelumab first-line maintenance for advanced urothelial carcinoma: results from patients with 12 months of treatment in javelin bladder 100 - mashupmd 
Business & Finance News Business & Finance News News Political News US & World News Medicine & Surgery.